Table 1 Patient and treatment characteristics (n = 20)
Age | Years, median (range) | 62 (44–79) |
Sex, n (%) | Male | 12 (60) |
ECOG PS, n (%) | 0 | 1 (5) |
1 | 4 (20) | |
2 | 8 (40) | |
3 | 5 (25) | |
4 | 2 (10) | |
Palliative prognostic index score, n (%) | < 4 points | 6 (30) |
4–6 points | 8 (40) | |
> 6 points | 6 (30) | |
Location, n (%) | Head | 12 (60) |
Body or tail | 8 (40) | |
Extent of disease, n (%) | Locally advanced | 3 (15) |
Metastatic | 17 (85) | |
Histopathology, n (%) | Adenocarcinoma | 18 (90) |
Anaplastic carcinoma | 1 (5) | |
Adenosquamous carcinoma | 1 (5) | |
Initial symptom, n (%) | Tarry stool | 10 (50) |
Hematochezia | 3 (15) | |
Hematemesis | 2 (10) | |
Abdominal pain | 1 (5) | |
Dizziness | 1 (5) | |
Fatigue | 1 (5) | |
Syncope | 1 (5) | |
None (incidentally endoscopically) | 1 (5) | |
Bleeding site, n (%) | Duodenum | 13 (65) |
Stomach | 6 (30) | |
Main pancreatic duct | 1 (5) | |
Previous treatment, n (%) | Systemic chemotherapy | 10 (50) |
None | 10 (50) | |
Previous bleeding management, n (%) | None | 17 (85) |
Duodenal stent | 2 (10) | |
Endoscopic injection of HSE | 1 (5) | |
Previous biliary or duodenal stenting, n (%) | Biliary SEMS | 8 (40) |
Biliary and duodenal SEMS | 2 (10) | |
Biliary plastic stent | 1 (5) | |
None | 9 (45) | |
Radiation schedule, n (%) | 8 Gy in a single fraction | 2 (10) |
20 Gy in 5 fractions | 14 (70) | |
30 Gy in 10 fractions | 4 (20) | |
Completion of PRT, n (%) | Yes | 20 (100) |